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Abstract. Multispectral imaging (MSI) is widely applied across various imaging modalities as 10 
a technique for measurement of blood oxygen saturation (OS) in vivo, consequently providing 11 
new information about physiology and disease development. This tutorial aims to provide a 12 
thorough introduction to the theory and application of MSI oximetry for researchers new to the 13 
field, whilst also providing detailed information for more experienced researchers. The optical 14 
theory underlying two-wavelength oximetry, three-wavelength oximetry, pulse oximetry, and 15 
multispectral oximetry algorithms are described in detail. The varied challenges of applying MSI 16 
oximetry to in vivo applications are outlined and discussed, covering: the optical properties of 17 
blood and tissue, optical paths in blood vessels, tissue auto-fluorescence, oxygen diffusion, and 18 
common oximetry artefacts. Essential image processing techniques for MSI are discussed, in 19 
particular, image acquisition, image registration strategies, and blood vessel line profile fitting. 20 
Calibration and validation strategies for MSI are discussed, including comparison techniques, 21 
physiological interventions, and phantoms. The optical principles and unique imaging 22 
capabilities of various cutting-edge MSI oximetry techniques are discussed, including 23 
photoacoustic imaging, spectroscopic optical coherence tomography, and snapshot MSI.  24 
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1. Introduction 62 
1.1. The application and utility of multispectral imaging oximetry 63 
Highly localized measurement of blood oxygen saturation (OS) within tissue is useful for establishing 64 
physiological norms, and for monitoring hyperoxia (i.e. elevated OS) and hypoxia (i.e. reduced OS); 65 
which can be cause or symptom of various diseases. For example, hyperoxia is associated with 66 
retinopathy of prematurity[1]; arterial occlusion induces hypoxia, with subsequent of tissue function[2]; 67 
and cancerous tumours can cause localized hypoxia due to excessive metabolic demand.[3,4] However, 68 
many commonly used oximetry techniques, including blood gas measurement and pulse oximetry, lack 69 
the spatial resolution or tissue specificity required to measure blood OS in a manner relevant for detail 70 
studies of physiology or disease development. Multispectral imaging (MSI) oximetry is an optical 71 
technique that utilises the OS-dependent absorption spectra of haemoglobin within blood to quantify OS 72 
with high spatial and temporal resolution. This makes MSI oximetry ideal for highly specific studies of  73 
OS in small blood vessels that supply tissue.[5]  74 
MSI oximetry can be applied with various imaging techniques to image blood vessels in different bodily 75 
tissues. For example, MSI retinal fundus cameras are utilized for measuring blood oxygen in the eye[6], 76 
and MSI microscopes can be used to measure oxygen within individual red blood cells.[5] Emerging 77 
imaging modalities such a photoacoustic tomography (PAT) and spectroscopic optical coherence 78 
tomography (S-OCT) have also been utilized for to provide enhanced oximetry imaging capabilities: 79 
PAT enables oximetry in deep tissue, and S-OCT provides simultaneous 3D mapping of both issue and 80 
OS (see Section 6).  81 
MSI oximetry has been applied to diverse applications in vivo, including measurement of blood OS in 82 
the spinal cord,[7] the brain,[8] muscle tendons,[9,10] the bowel,[11] the oral microvasculature,[12]  83 
and the skin.[13] In the eye, MSI oximetry has established the oxygen dynamics and physiological 84 
norms of the retina,[6] the choroid,[14] the bulbar conjunctiva,[15] and the episcleral blood vessels.[15]  85 
Various diseases have been studied with MSI oximetry, including diabetic retinopathy,[16,17] 86 
glaucoma,[18–20] retinal vessel occlusion,[2,6] stroke,[8] rheumatoid arthritis,[10] diabetic foot 87 
ulcers,[13,21] and cancerous tumor development.[3,22] For the full applications of oximetry to the 88 
monitoring of retinal disease, readers are referred to recent reviews.[6,23,24] 89 
1.2. The principle of optical oximetry 90 
 91 
The theory of MSI oximetry is fundamentally the same across for all imaging techniques, in that all MSI 92 
modalities measure the OS-dependent absorption of light by haemoglobin (see Figure 1). Haemoglobin 93 
is the dominant absorber of light in blood, with typically ~250 million haemoglobin molecules inside a 94 
normal red blood cell  (RBC).[25] The function of haemoglobin is to transport oxygen around the body 95 
by reversible binding of oxygen to four heme sub-units. These heme units strongly absorb blue and 96 
green light, giving haemoglobin its distinctive red colour.* When oxygen binds or unbinds to 97 
hameoglobin, the optical absorbance properties of haemoglobin are altered, resulting in a change in the 98 
optical absorption spectra of blood (see Figure 1).† The affinity of haemoglobin for oxygen is described 99 
the sigmoid-shaped oxygen dissociation curve, which varies with temperature and pH, as well as 100 
                                                     
* Note that contrary to popular belief, deoxygenated blood is not blue. The blue appearance of veins through skin 
tissue is due to the combination of multiple effects, including optical scattering and absorption by tissue, 
combined with quirks of human  visual perception.[157] 
† The change in optical absorbance of haemoglobin as oxygen binds or unbinds is due to a change in electron 
configuration of haemoglobin. 
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between species.[26] Each haemoglobin molecule can bind up to four oxygen molecules: one to each 101 
heme group – resulting in five possible states for each individual hameoglobin molecule: 0%, 25%, 102 
50%, 75%, and 100% oxygen occupancy. A population of many haemoglobin molecules can be of an 103 
average OS anywhere between 0 – 100% OS. 104 
The OS of blood is defined as: 105 
 OS = 
𝐶𝑂2𝐻𝑏
𝐶𝐻𝑏𝑇
=  
𝐶𝑂2𝐻𝑏
𝐶𝑂2𝐻𝑏+ 𝐶𝐻𝑏
 , 1 
Where 𝐶𝐻𝑏𝑇, 𝐶𝑂2𝐻𝑏, and 𝐶𝐻𝑏 are, respectively, the molar concentrations of total haemoglobin, fully 106 
oxygenated haemoglobin, and fully deoxygenated haemoglobin. For typical arteries (i.e. blood vessels 107 
carrying oxygenated blood away from the heart), nominal OS is in the range 94 - 98%, corresponding 108 
to a partial pressure of oxygen (pO2) of ~ 100 mmHg. In typical veins (i.e. deoxygenated blood vessels 109 
carrying blood towards the heart), nominal OS is ~70%, corresponding to a  pO2 ~ 40 mmHg.[27] 110 
However, OS values within the body vary considerably, depending on parameters, such as the 111 
atmospheric partial pressure of oxygen (pO2), blood flow velocity, and metabolic demand by tissue. For 112 
example, the metabolic remand for oxygen in retinal tissue is particularly high, resulting in venous OS 113 
~60%.[28] 114 
The absorption spectra of fully oxygenated haemoglobin (O2Hb) and fully deoxygenated haemoglobin 115 
(Hb) are shown in Figure 1. The spectra exhibit several isosbestic wavelengths at which the extinction 116 
coefficients of haemoglobin are insensitive to changes in OS, interspersed with spectral bands where the 117 
extinction coefficients vary strongly with OS. Two-wavelength oximetry, a simple approach to 118 
oximetry, exploits the approximately linear relationship between OS and the ratio of measured optical 119 
density at an isosbestic waveband to the optical density at an OS-sensitive waveband. The strength of 120 
such a ratiometric technique arises from the simplicity of application: however, the assumption of 121 
linearity, based on the Beer-Lambert law is an over simplification, where presence of optical scattering 122 
and additional chromophores in neighboring tissue, or indeed other species of Hb within the blood, can 123 
lead to inaccuracies.[29] The use of multispectral imaging with various degrees of sophistication and 124 
complexity provides scope for increased accuracy and robustness in oximetry. Simply put, recording the 125 
absorption of blood at more wavelengths enables more unknown parameters to be accounted for, 126 
improving oximetry (see Section 2.4). 127 
 128 
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Figure 1. The optical absorption spectra of oxygenated haemoglobin 
(HbO2)[the red line] and deoxygenated haemoglobin (Hb)[the blue line]. 
Figure created from spectroscopic data tabulated by S. Prahl (1999).[30] The 
units for extinction coefficient are per centimetre per mole (cm-1 M-1). 
1.3. Milestones in the development of MSI oximetry technology 129 
 130 
The pioneering MSI oximetry studies of retinal OS were undertaken in the 1960s, establishing the 131 
fundamental principles of two-wavelength oximetry upon which all subsequent research has been 132 
built.[31–33] Initially, retinal oximetry was calibrated by ex vivo blood gas measurement. However, the 133 
advent of fingertip pulse oximetry subsequently enabled simpler calibration by non-invasive 134 
measurement of arterial OS via the fingertip (see Section 2.2).[34] Later oximetry studies advanced the 135 
field by establishing techniques such as three-wavelength oximetry,[35] scanning laser retinal MSI,[36] 136 
and high spectral resolution retinal spectrophotometry.[37,38] For more detailed information on the 137 
development of retinal oximetry, the reader is referred to the 2014 retrospective by Jim Beach.[24]  138 
In the late 1990s, digital imaging technology began to replace photographic cameras, paving the way 139 
for automated computational analysis of images.[24,39] The mid-to-late 2000s saw the development of 140 
two commercially available retinal oximetry systems; the Oxymap T1 retinal oximeter (Oxymap ehf, 141 
Iceland) [40] and the Imedos retinal oximeter (Imedos Systems UG, Germany).[17] Advances in 142 
computational power and techniques enabled automatic oximetry, consequently enabling the study of 143 
numerous retinal diseases by ophthalmologists.[23]  144 
In the past decade, emerging imaging modalities have enabled MSI oximetry to be applied to 145 
increasingly diverse in vivo applications. Snapshot MSI systems have enabled oximetry with sub-second 146 
temporal resolution, enabling observations of fast biological processes such as oxygen diffusion into the 147 
microvasculature [15] and MSI endoscopes have provided measurements in tissue that are not accessible 148 
with traditional imaging techniques, e.g. within the bowel.[11] Photoacoustic techniques have enabled 149 
deep-tissue oximetry of the brain, cancer tumors, and entire small animals,[41] and spectroscopic optical 150 
coherence tomography (S-OCT) has enabled complimentary 3D mapping of OS and tissue structure.[42] 151 
Across all MSI modalities, advancement and application of MSI oximetry technology has yielded 152 
considerable insights into physiological norms and disease development.[6] Section 6 provides further 153 
details on the applications and optical-principles underpinning these emerging MSI modalities. 154 
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2. Theory of oximetry 155 
2.1. Two-wavelength oximetry 156 
2.1.1. Derivation of two-wavelength oximetry 157 
The simplest and most commonly used form of oximetry is two-wavelength oximetry, which is based 158 
on the Beer-Lambert law of light transmission through a medium: 159 
  Iλ = Iλo exp (−𝑐ελ d) 2 
where Iλ is the intensity of the light transmitted through the medium,  Iλo is the intensity of the light 160 
incident upon blood, c is the molar concentration of absorbers (i.e. haemoglobin) within blood [M], ελ 161 
is the wavelength-dependent molar extinction coefficient of haemoglobin [cm-1M-1], and d is the optical 162 
path length of light through the blood [cm]. For blood, ελ, is defined by: 163 
 𝜀𝜆 = (𝑂𝑆  𝜀𝜆𝑂2𝐻𝑏
) +((1 - OS) 𝜀𝜆𝐻𝑏), 3 
where OS is the fractional blood oxygen saturation (range 0-1), ελO2Hb
 is the molar extinction 164 
coefficient of fully oxygenated haemoglobin, and ελHb is the molar extinction coefficient of 165 
deoxygenated haemoglobin. No other chromophores are included in this simplified model. The 166 
transmission, T𝜆, of the blood is defined as: 167 
 𝑇𝜆 = (
𝐼λ
𝐼λo
). 4 
The optical-density of the blood, ODλ, is then defined as: 168 
 𝑂𝐷λ = −𝑙𝑜𝑔(𝑇𝜆)   = 𝑙𝑜𝑔 (
𝐼λ
𝐼λo
)  = c d ελ. 5 
Assuming that c and d are identical at both wavelengths, then the optical-density ratio, ODR, is: 169 
 𝑂𝐷𝑅 =
𝑂𝐷λ1
𝑂𝐷λ2
 =
𝑐 𝑑 𝜀𝜆1
𝑐 𝑑 𝜀𝜆2
=
𝜀𝜆1
𝜀𝜆2
 . 6 
If one wavelength is chosen to be isobestic, i.e. insensitive to changes in OS, and the other wavelength 170 
is chosen to be sensitive to changes in OS, then ODR will be linearly proportional to OS.[31] If nominal 171 
OS values are known by independent means, then ODR can be empirically calibrated to OS by fitting 172 
ODR to the equation of a straight line, i.e.: 173 
 𝑂𝑆 = 𝑎 ∗ 𝑂𝐷𝑅 + 𝑏, 7 
where a and b are empirically derived calibration coefficients obtained by plotting ODR vs. OS. Thus, 174 
from measuring transmission at two wavelengths, ODR can be calculated, from which OS can be 175 
estimated by empirical calibration.  176 
2.1.2. Optimal vessel transmission and wavelength combinations for two-wavelength oximetry 177 
For accurate oximetry, blood vessels must neither be too transparent nor too opaque. Based upon work 178 
by Assendelft (1970),[43] Smith derived the following optimal transmission for a blood vessel in order 179 
to minimize sensitivity to measurement noise.[44] Smith’s derivation starts from the definition of 180 
optical-density, ODλ: 181 
 𝑂𝐷λ = − 𝑙𝑜𝑔  (𝑇λ) =  
𝑙𝑛(𝑇λ)
𝑙𝑛(10)
. 8 
The absolute error function for ODλ is then found by differentiating: 182 
 𝛥𝑂𝐷λ =
𝑑𝑂𝐷λ
𝑑𝑇λ
𝛥𝑇λ =  
𝛥𝑇λ
𝑙𝑛 (10)
1
𝑇λ
 . 9 
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The fractional error function of ODλ is then: 183 
 
𝛥𝑂𝐷λ
𝑂𝐷λ
=
𝛥𝑇λ
𝑇λ𝑙𝑛(𝑇λ)
 .      10 
To minimise the relative error of ODλ, the first derivative, with respect to 𝑇λ, of Equation 10 must be 184 
found, and then set to zero. 185 
 
𝑑(𝛥𝑂𝐷λ/𝑂𝐷λ)
𝑑𝑇λ
=
𝑙𝑛 (𝑇λ) + 1
[𝑇λ 𝑙𝑛(𝑇λ)]2
 𝛥𝑇λ = 0 .   11 
Discarding the non-physical solution of Tλ = 0, leaves the following solution: 186 
 
𝑙𝑛(𝑇λ) + 1 = 0, 
=> 𝑇λ = 1/e = 36.8%, 
=> 𝑂𝐷λ= 0.434. 
 12 
This solution indicates that transmission of 36.8% or an optical-density of 0.434 will be optimal for 187 
minimizing errors due to uncertainties in transmission in two-wavelength oximetry. Expanding this 188 
further, Smith showed that the transmission range between 10% and 70% is broadly optimal for 189 
oximetry; outside this transmission range, the error function associated with measurement errors grows 190 
rapidly, so accurate oximetry becomes untenable.[44] 191 
In the same study, Smith (1999) theoretically investigated the noise-sensitivity of various waveband 192 
combinations for two-wavelength oximetry, concluding that optimal waveband combinations for retinal 193 
oximetry would be 635 nm & 965 nm as well as 488 nm & 635 nm.[44] However, these theoretical 194 
waveband combinations may not be practical because they do not take into account the practical 195 
constraints of available light sources, tissue irradiance limits, pigmentation, and tissue scattering 196 
properties.  197 
In practice, the optimal-wavelength combination for a given application is dictated by the calibre of 198 
blood vessels being investigated, potential sources of confounding absorption by tissue, and the 199 
constraints of the illumination and imaging systems. For two-wavelength retinal oximetry, the 200 
wavelength combination of wavebands ~600 nm (OS sensitive) and ~570 nm (isobestic) has been widely 201 
adopted. Calculated transmissions at several wavelengths of blood vessels of a range of calibers 202 
containing fully and partially oxygenated blood are shown in Figure 2. Scattering is neglected and the 203 
wavelength and caliber ranges for accurate oximetry are highlighted. 204 
 205 
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 206 
Figure 2. Calculated single-pass transmissions for blood vessels at various wavebands assuming 207 
single-pass transmission and the concentration of haemoglobin to be 20 mM. (A) 100% OS, (B) 208 
70% OS. No other chromophores or optical scattering was modelled. 209 
2.1.3. Corrections for blood vessel diameter and tissue pigmentation in two-wavelength oximetry 210 
 211 
Hickam et al. (1963) noted that the observed ODR of a blood vessel is dependent on the diameter of that 212 
blood vessel.[32] Exemplar experimental data verifying this effect shown in Figure 3. It is thought that 213 
this ODR diameter-dependence is due to scattering of light and other terms which are not incorporated 214 
in the normal Beer-Lambert law, and thus not included in the theory of two-wavelength oximetry.[45] 215 
The resultant ODR offset between blood vessels of different diameters is of particular importance in 216 
experiments where blood vessels change in diameter (i.e. if the vessels dilate or contract). Stimuli such 217 
as hypoxia, hyperoxia, and, in the retina, flicker-light stimulation can cause such responses (see Section 218 
5.3.3), and thus potentially introduce changes in ODR that are not due to changes in OS alone.  219 
 220 
This vessel diameter-dependent effect is also problematic for oximetry of veins, which are typically 221 
larger than arteries; this can lead to a spurious decrease in venous OS estimated by two-wavelength 222 
oximetry. To compensate for this, Hammer et al., (2008) implemented an empirically-derived size-223 
dependent venous OS correction factor.[29] A similar calibration issue is associated with tissue 224 
pigmentation: in two-wavelength oximetry, venous OS can spuriously appear to increase with increasing 225 
retinal pigmentation. Again, Hammer et al., (2008) implemented an empirically-derived, pigmentation-226 
dependent, venous OS-correction factor to compensate for this effect.[29]  227 
 228 
 229 
 230 
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Figure 3.  ODR vs. OS for fluorinated ethylene propylene 
(FEP) capillaries filled with ex vivo heparinised equine 
blood. The 150 µm capillary has a greater baseline ODR than 
the 100 µm capillary, but change in ODR for a given change 
in OS is approximately the same for both (fitted lines). 
Equipment used: FEP capillaries imaged with a retinal 
fundus camera modified with a snapshot multispectral 
imaging system. OS of ex vivo equine blood verified by an 
optical blood gas analyser [GEM OPL, Instrumentation 
Laboratories] with a quoted OS uncertainty of ± 1.8% (not 
depicted). OS of blood was varied by addition of sodium 
dithionite.[46] Vertical error bars show the standard 
deviation of ODR along the length of the capillary section 
analysed. 
 231 
2.2. Pulse oximetry 232 
Pulse oximetry is widely used to non-invasively monitor arterial OS via the fingertip. Pulse oximetry 233 
uses the varying optical absorption due to pulsatile arterial blood to remove the influence of background 234 
absorbance by tissue and venous blood (assumed to be non-pulsatile); in this manner, pulse oximetry is 235 
similar to photoplethysmography.[47] Yet, by calculating the ODR of the pulsating absorbance 236 
component, two-wavelength oximetry can then be applied to estimate peripheral arterial OS.[34] To 237 
enable measurement through relatively thick tissue (i.e. in the range of one to five centimeters) pulse 238 
oximeters typically use wavelengths which are minimally absorbed and scattered by blood or tissue, e.g. 239 
650 nm and 800 nm. Pulse oximeters are calibrated across many subjects by relating average ODR to 240 
average arterial OS, as measured by an ex vivo blood-gas analyzer. In humans, pulse oximeters are not 241 
calibrated for OS < 80% due to ethical constraints,[48,49] and generally have an uncertainty quoted at 242 
± 2%.[50] Pulse oximeters for animal use may, however, be calibrated for lower oxygen saturations due 243 
to less stringent ethical constraints. 244 
In adult humans, the fingertip is the usual location for monitoring arterial OS, but pulse oximetry 245 
measurements can also be made via the earlobe[51] and the big toe.[52] In infants, being smaller than 246 
adults, pulse oximetry measurements can be made via alternative tissue beds, including via the palm of 247 
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the hand, the sole of the foot, and the scrotum.[53,54] However, it should be noted that pulse oximeter 248 
manufacturers typically do not provide calibration for non-fingertip applications. The reliability of pulse 249 
oximeters can be reduced by low blood flow, caused by factors such as pressure on the measurement 250 
tissue, or by cold temperatures. As an example, the earlobe is particularly sensitive to reduced blood 251 
flow due to the pressure of clip-on pulse oximeters.[51] Additionally, diseases that affect the optical 252 
properties of blood, e.g. sickle cell anemia, may interfere with pulse oximetry.[55] Further, commercial 253 
pulse oximeters are often ‘black box’ devices with non-optional features such as time-integrated signal 254 
averaging to reduce noise in measurement. Consequently, when using pulse oximetry as a reference for 255 
MSI oximetry, the limitations of both the equipment, and the physiology of the subject should be 256 
carefully considered to ensure a relevant comparison. 257 
2.3. Three-wavelength oximetry 258 
2.3.1. Derivation of three-wavelength oximetry 259 
Three-wavelength oximetry was developed by Pittman and Duling in 1975, and advanced the field of 260 
oximetry by incorporating optical scattering parameters into the optical transmission models of 261 
blood.[35] The technique requires three wavebands, proximal to each other in the haemoglobin 262 
absorption spectrum: two isobestic wavelengths are used to estimate the contribution by optical 263 
scattering, and a third wavelength is used as for OS sensitivity.  264 
The derivation of the three-wavelength oximetry model starts with the modified Beer-Lambert law: 265 
 𝑂𝐷𝜆 =  𝜀𝜆 𝑐 𝑑 + 𝐵𝜆, 13 
where Bλ is a term describing the effect of scattering on optical-density. For two proximal wavelengths,  266 
λ1 and λ2, 𝐵λ will be approximately equal for both, i.e.: 267 
 𝐵𝜆1 = 𝐵𝜆2 =  𝐵, 14 
  𝑂𝐷𝜆1 =  𝜀𝜆1 𝑐 𝑑 +  𝐵, 15 
  𝑂𝐷𝜆2 =  𝜀𝜆2 𝑐 𝑑 +  𝐵. 16 
Solving Equations 15 and 16 simultaneously yields: 268 
 𝐵 =
(𝜀𝜆1/𝜀𝜆2) 𝑂𝐷𝜆1 − 𝑂𝐷𝜆2 
(𝜀𝜆1/𝜀𝜆2) − 1
. 17 
It should be noted here, that if the term of (ελ1/ελ2) is close to 1, then minor errors in the measurement 269 
of OD can result in large errors in the estimation of 𝐵.[44] However, assuming the value of 𝐵 is 270 
estimated accurately, then it can be incorporated into Equation 7 to yield: 271 
 𝑂𝑆 = 𝑎 (
𝑂𝐷𝜆3+𝐵 
𝑂𝐷𝜆𝑟𝑒𝑓+𝐵
) +  𝑏, 18 
Where, 𝑂𝐷𝜆3 is the optical-density at a third, oxygen sensitive, wavelength; 𝑂𝐷𝜆𝑟𝑒𝑓 is the optical-272 
density at one of the isobestic wavelengths; and 𝑎 and 𝑏 are empirically derived calibration coefficients. 273 
Equation 18 is of the form of the equation of a straight line, so the OD ratio can be calibrated to OS in 274 
similar manner to two-wavelength oximetry, i.e. by plotting at least two known OS reference points 275 
versus the product of the right side of Equation 18.[35] 276 
2.3.2. Discussion, and the application of, three-wavelength oximetry  277 
 278 
Three-wavelength oximetry is somewhat limited in that it is only applicable for waveband triads that 279 
exhibit near-identical scattering properties, somewhat similar absorption properties, whilst including 280 
two isobestic wavebands and one OS-dependent contrast waveband. For example, Pittman and Duling 281 
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(1975)[35] found that blue wavelengths  (420 – 450 nm) are particularly susceptible to spurious errors 282 
in the estimation of the parameter, 𝐵, due to the large variations of 𝜀𝜆, and thus large variations of 283 
refractive index, across this waveband. Instead, Pittman and Duling employed the more favourable 284 
wavelength triad of 520 nm, 546 nm, and 555 nm, reporting ± 1% OS uncertainty for ex vivo blood 285 
samples.[35]  286 
Smith (1999)[44] suggested the following wavelength triads as theoretically optimal for three-287 
wavelength oximetry of retinal blood vessels: (1) 488 nm, 635 nm, and 905 nm; (2) 600 nm, 635 nm, 288 
and 905 nm; (3) 635 nm, 720 nm, and 905 nm. Whilst three-wavelength oximetry may offer improved 289 
accuracy over two-wavelength oximetry by accounting for scattering, three-wavelength oximetry still 290 
requires calibration of ODR to blood of known OS, and the choice of potential imaging wavebands is 291 
rather limited. As such, three-wavelength oximetry has been largely superseded by multispectral 292 
oximetry algorithms (see Section 2.4). 293 
2.4. Multispectral oximetry  294 
2.4.1. Theory and derivation of multispectral oximetry algorithms 295 
Multispectral and hyperspectral‡ oximetry algorithms estimate OS by computationally fitting 296 
experimentally determined blood vessel transmission values to a theoretical optical model incorporating 297 
OS and other optical parameters, e.g. to model the effects of optical scattering or background 298 
pigmentation. Unlike two- and three-wavelength oximetry, this optical model approach enables 299 
multispectral oximetry algorithms to be applied without implicit empirical calibration; however, 300 
validation of oximetry is a key challenge for applying multispectral oximetry (see Section 2.4.2). 301 
The parameters included in multispectral oximetry models vary between studies; some parameters are 302 
“hard wired”, and some are estimated from the recovered fit to transmission profile. Table 1 provides a 303 
summary of hard-wired and recovered parameters in published multispectral oximetry models. As a 304 
minimum,  multispectral oximetry models will “hard wire” in the OS-dependent extinction coefficients 305 
of haemoglobin, 𝜀𝜆𝑂2𝐻𝑏
 and 𝜀𝜆𝐻𝑏. Further terms may be added to account for various other parameters, 306 
including concentration of haemoglobin, blood-vessel diameter, optical-path through a blood vessel (see 307 
Section 3.7), optical back scatter by blood, pigmentation of surrounding tissue, and contrast reduction 308 
due to overlying tissue and scattering by the ocular media. As a general rule, the maximum number of 309 
parameters that can be estimated to a model cannot be greater than the number of independent 310 
measurements incorporated in the model,§ thus the more parameters that are modelled, the more 311 
wavelengths are required to apply the model. A summary of multispectral oximetry models reported in 312 
the literature, and the optical parameters they include, is provided in Table 1. 313 
 314 
van der Putten et al. (2017) reported the most sophisticated multispectral oximetry model to date.[7] 315 
Their model builds upon the thoroughly validated model developed by Smith et al., (2000), which is 316 
applied to directly imaged blood vessels.[56] The derivation of their model starts with the Beer Lambert 317 
law:  318 
 𝑂𝐷𝜆 = 𝑙𝑜𝑔10(𝑇λ) =  𝜀𝜆 𝐶𝐻𝑏𝑇 𝑑, 19 
                                                     
‡ There is no formal definition of multispectral or hyperspectral imaging. Both techniques follow the same 
principle, but multispectral imaging typically incorporates fewer than ten wavebands, often non-continuous, and 
hyperspectral imaging can incorporate several tens or hundreds of contiguous wavebands (see Table 1 for 
examples). For simplicity, we will refer primarily to multispectral imaging in this paper. 
§ In simplistic terms, one can imagine the example of a straight-line fit, which requires at least two data points, 
from which two parameters – gradient and intercept – can be estimated.  
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where 𝐶𝐻𝑏𝑇 is the total molar concentration of haemoglobin. From Equation 1,  𝐶𝐻𝑏𝑇 =  𝐶𝑂2𝐻𝑏 + 𝐶𝐻𝑏, 319 
so 𝑂𝐷𝜆 can be written as: 320 
 𝑂𝐷𝜆 = 𝜀𝜆𝑂2𝐻𝑏 𝐶𝑂2𝐻𝑏 𝑑 + 𝜀𝜆𝐻𝑏𝐶𝐻𝑏𝑑, 20 
Rearranging gives: 321 
 𝑂𝐷𝜆 = 𝐶𝐻𝑏𝑇𝑑[(𝜀𝜆𝑂2𝐻𝑏 − 𝜀𝜆𝐻𝑏)𝑂𝑆 +  𝜀𝜆𝐻𝑏]. 21 
To this, an additive reduced scattering coefficient  µλ
′  (measured by Faber et al., (2004)[57]) is added 322 
to account for scattering of light by red blood cells. This gives: 323 
 𝑂𝐷𝜆 = 𝐶𝐻𝑏𝑇𝑑[(𝜀𝜆𝑂2𝐻𝑏 −  𝜀𝜆𝐻𝑏)𝑂𝑆 + 𝜀𝜆𝐻𝑏]+µ𝜆
′ 𝑑. 22 
The contribution of single- and double-pass light paths through a blood vessel [58] can be accounted for 324 
by adding two multiplicative factors, 𝛼 and 𝛽, representing the fraction of light rays that undergo single-325 
or double-pass transmission respectively (see Section 3.7). Additionally, 𝑂𝐷𝜆 can be related to 326 
transmission by 𝑇λ = 10
−𝑂𝐷𝜆. Therefore, Equation 22 can be rewritten as:  327 
 
𝑇λ = [𝛼 10
−(𝐶𝐻𝑏𝑇 𝑑[(𝜀𝜆𝑂2𝐻𝑏− 𝜀𝜆𝐻𝑏)𝑂𝑆+ 𝜀𝜆𝐻𝑏]+µ𝜆
′ 𝑑) +
𝛽10−(2𝐶𝐻𝑏𝑇 𝑑[(𝜀𝜆𝑂2𝐻𝑏− 𝜀𝜆𝐻𝑏)𝑂𝑆+ 𝜀𝜆𝐻𝑏]+2µ𝜆
′ 𝑑)]. 
23 
To advance this model, van der Putten et al., incorporated a novel contrast-reduction parameter, 𝐾, into 328 
their multispectral oximetry algorithm.This parameter models the effects of tissue overlying a directly 329 
imaged vessel. 𝐾 is described as an arbitrary increase in greyscale intensity (𝐼𝑐), both in the centre of 330 
the vessel (𝐼𝑣) and outside the vessel (𝐼𝑜): 331 
 𝐾 =
𝐼𝑣+𝐼𝑐
𝐼𝑜+𝐼𝑐
 . 24 
Thus, transmission can be re-written as: 332 
 𝑇′λ = (
𝐼𝑣+𝐼𝑐
𝐼𝑜+𝐼𝑐
)  = 𝑇λ(1 − 𝐾) + 𝐾. 25 
and the full optical transmission model can then be written as: 333 
 
𝑇′λ = [𝛼 10
−(𝐶𝐻𝑏𝑇 𝑑[(𝜀𝜆𝑂2𝐻𝑏−𝜀𝜆𝐻𝑏)𝑂𝑆+ 𝜀𝐻𝑏(𝜆)]+µ𝜆
′ 𝑑)
+ 𝛽10−(2𝐶𝐻𝑏𝑇 𝑑[(𝜀𝜆𝑂2𝐻𝑏− 𝜀𝜆𝐻𝑏)𝑂𝑆+ 𝜀𝜆𝐻𝑏]+2µ𝜆
′ 𝑑)] 
(1 − 𝐾) + 𝐾. 
 26 
To date, this is the most sophisticated multispectral oximetry algorithm developed and, without direct 334 
calibration, has provided plausible oximetry when utilised for in vivo experiments. For example, the OS 335 
of the spinal cord dorsal vein in rats was estimated to be 67.8 ± 10.4% at normoxia (mean ± SD, n = 336 
4),[7] and the OS of healthy blood vessels in murine tendons was estimated to be ~95%.[10] Despite 337 
these encouraging results, there are still numerous challenges associated with validation of multispectral 338 
oximetry algorithms. These are discussed extensively in the next section. 339 
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Table 1. Summary of notable studies utilizing multispectral oximetry algorithms. 340 
Study 
Oximetry 
application 
Wavebands 
“Hard Wired” 
parameter values 
Estimated 
parameters 
recovered 
van der Putten et 
al. 2017.[7] 
Rat spinal cord 
dorsal vein 
546, 560, 570, 
584, 590, and 
600 nm 
ε, S. OS, c, S, d, K, 𝛼, 𝛽. 
van der Putten et 
al. 2017.[9,10] 
Mouse muscle 
tendon capillary 
 
410, 420, 430, 
435, 440, and 
450 nm 
ε, S. OS, c, S, d, K, 𝛼, 𝛽. 
Hendargo et al., 
2015.[59] 
 
Mouse skin 
microvasculature 
540, 560, 580, 
and 610 nm 
ε. OS, c. 
Clancy et al. 
2015.[11] 
Porcine bowel 
440 – 700 nm, 
28 wavebands. 
ε. OS, c, S. 
Fernandes-
Ramos et al. 
2014.[5] 
Red blood cells 
(ex vivo) 
560 – 600 nm, 
8 wavebands 
ε. OS, c. 
Mordant et al. 
2014.[19] 
Retinal oximetry 
of glaucoma 
patients 
556 – 650 nm 
47 wavebands 
ε, S. OS, c, d, 𝛼, 𝛽. 
Chin et al. 
2012.[13] 
Diabetic foot 
ulcers in humans 
500 – 600 nm, 
15 wavebands 
ε. OS, c. 
Yudovsky et al. 
2011.[21] 
Diabetic foot 
ulcers in humans 
550 – 660 nm, 
15 wavebands 
ε, εmel. ΔOS, c, cmel, S. 
Mordant et al. 
2011.[60] 
Human retina 
500 – 650 nm 
300 wavebands. 
ε, S. OS, c, d, 𝛼, 𝛽. 
Sorg et al. 2008. 
[4] and 2005.[3] 
Mouse tumor 
model 
505 – 575 nm, 
16 wavebands 
ε. OS, c, S, 𝛼, 𝛽. 
Alabboud et al. 
2007.[61] 
Human retina 
500 – 700 nm 
27 + wavebands 
ε, S. OS, c, d, 𝛼, 𝛽. 
Smith et al. 
2000.[62] 
Human retina 
488, 635, 670, 
752, 830 nm. 
ε. OS, c, S, d, 𝛼, 𝛽. 
Drewes  et al. 
1999.[63] 
Human retina 
629, 678, 821, 
899 nm. 
ε. OS, c, S, d. 
 
Schweitzer et al. 
1999.[64] 
Human retina 
510 – 586 nm, 
76 wavebands 
ε, εmel. OS, c, d, 𝛼, 𝛽. 
Key: ε = extinction coefficient of 𝐻𝑏 and 𝑂2𝐻𝑏 εmel = extinction coefficient of melanin pigmentation, S = 341 
scattering contribution; c = concentration of Hb, 𝛼, 𝛽 = single and double pass contribution factors respectively; 342 
d = diameter of blood vessels; K = contrast reduction factor. 343 
2.4.2. Calibration and validation of multispectral oximetry algorithms  344 
 345 
Potential errors in estimation of OS from MSI oximetry models, e.g. due to the influence of transmission 346 
quantification error or ill-defined/poorly-modelled systematic parameter(s), have not been thoroughly 347 
and robustly explored in the literature. In theory, the multi-parameter fit should, minimise errors in OS 348 
due to error in transmission measurement at a single waveband, with robustness of fit increasing with 349 
the number of wavebands. Ideally, further research is required to quantify potential measurement errors. 350 
Like the work of Smith for two- and three-wavelength oximetry, such error minimisation research would 351 
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likely take the form simulations.[44] Direct experimental validation of MSI oximetry models, in 352 
absolute terms, remains a fundamental challenge in the field of oximetry. 353 
In the retina, (the vascular bed most commonly studied with oximetry) estimated OS can be compared 354 
to well-established reference values (e.g. 96% for arteries and 54% for veins).[40] However, in many 355 
other tissues, there are often no known absolute reference values for OS for the physiological context in 356 
which the MSI oximetry model is being applied. Further, blood vessels of interest are typically 357 
embedded in tissue that is both physiologically, and optically, complex; this complicates measurement 358 
and comparison. Further, in applications such as tumor development, OS is likely to be very different 359 
from established physiological norms due to abnormal metabolic demands.[3,4,22]  360 
Healthy control subjects can be used as a qualitative reference for comparison to diseased subjects, and 361 
to help infer inaccurate or spurious OS estimation. However, other factors such as anesthesia, local 362 
metabolic demand, inter-subject variability, and oxygen diffusion may affect blood flow rate and OS in 363 
healthy controls. Hence, it can  potentially be challenging to verify if perceived discrepancies in OS are 364 
due to artifacts introduced by a flawed MSI oximetry algorithm, or if they are actually due to real 365 
physiological variations.[59] 366 
In living subjects, pulse oximetry can only be used to only measure systemic arterial OS. Oxygen 367 
sensitive nanophosphors can be used to measure local partial pressure of oxygen, but such 368 
nanophosphors require biochemical expertise and complex phosphorescence lifetime imaging 369 
equipment; this presents a considerable barrier to entry for researchers (see Section 5.3.2 for more 370 
details).[65] Further, validation of in vivo multispectral oximetry algorithms by using artificial phantoms 371 
may not be possible due to the significant differences in optical properties between phantom construction 372 
materials (e.g. quartz or plastic capillaries) and real tissue (see Section 5.2 for more details on phantom 373 
design). Oxygen-sensitive interventions that induce changes in the OS of blood, do however, allow 374 
researchers to validate oximetry by inducing artificial changes in OS distinct from physiological norms, 375 
enabling inter-subject comparison. Such interventions are discussed in detail in Section 5.3.3.  376 
Fundamentally, the challenge of validating multispectral oximetry algorithms is that multispectral 377 
oximetry algorithms are often the only method capable of providing OS measurements in many 378 
physiological contexts, so no direct calibration with a “gold standard technique” is possible. Instead, the 379 
field has to rely on indirect qualitative validation provided by comparison to controls, and by OS –380 
altering interventions to provide context for multispectral oximetry results, and build a case for 381 
convincing oximetry measurements from context.  382 
3. Challenges for in vivo multispectral imaging oximetry  383 
3.1. Optical absorption by haemoglobin variants and blood plasma 384 
For understanding errors and uncertainties in oximetry, it is useful to consider the optical properties of 385 
blood constituents, other than haemoglobin (Hb), which may absorb or scatter light, and how these may 386 
alter the optical transmission of blood vessels. For example, variant globin proteins, blood plasma, and 387 
cells within blood. 388 
Haemoglobin has two main variants, namely methemoglobin (MetHb), where the iron in heme groups 389 
is Fe3+ instead of Fe2+, and carboxyhemoglobin (CoHb), where carbon monoxide is bound to 390 
haemoglobin. If present in the blood, MetHb and CoHb can contribute spectral absorption that is similar 391 
to normal Hb.[66–68] However, the concentration MetHb and CoHb are normally present only at low 392 
concentrations in blood and are thus generally ignored for oximetry.[68] Another molecule similar to 393 
Hb is neuroglobin, which supplies oxygen to nervous tissue, such as the brain and retina.[69] However, 394 
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the extent to which neuroglobin can be found in the blood is currently unclear.[70–72] Other proteins 395 
similar to Hb can sometimes be found in the blood. For example, myoglobin (Mb) – a protein which 396 
supplies oxygen to muscle tissue - can be found in blood when a subject has undergone skeletal or 397 
cardiac muscle damage, e.g. due to a heart attack or traumatic injury.[73,74] The absorption spectra of 398 
Mb is broadly similar to Hb, but with weaker optical absorption because Mb contains only a single heme 399 
group compared to the four heme groups of Hb.[75] Mb is not considered in MSI oximetry, even in 400 
experiments that may cause muscle damage.  401 
White blood cells account for <1% of whole blood volume, but do not contribute significant absorption 402 
or scattering,[76] and are not considered in oximetry. However, blood plasma is ~55% of the total 403 
volume of human blood, and contains many proteins which can absorb and scatter light.[77] When 404 
isolated from whole blood, blood plasma has a pale-yellow coloration due to strong absorption by serum 405 
albumin at wavelengths < 550 nm. Additionally, blood plasma auto-fluoresces under ultraviolet and blue 406 
light exposure, [78] which could potential induce errors in oximetry (see Section 3.4 for more on auto-407 
fluorescence). However, to the best of our knowledge, no oximetry studies to date have incorporated the 408 
optical parameters of blood plasma.  409 
3.2. Pigmentation within tissue  410 
Melanin is the main pigment chromophore** of concern for oximetry. Melanin strongly absorbs blue and 411 
green light, with red light less strongly absorbed.[79] If present in high concentration, absorption by 412 
melanin may be sufficient to make meaningful MSI oximetry challenging. Melanin is particularly 413 
abundant in the skin and retina, and as such, is particularly relevant for oximetry of blood vessels in 414 
these tissue beds. Retinal melanin can be quantified via the proxy of assessment of iris coloration; 415 
subjects with low retinal melanin tend to have blue iris coloration, whereas subjects with a high degree 416 
of retinal melanin tend to display brown iris coloration.[80]  417 
The non-uniform distribution of melanin in retinal tissues introduces considerable variability in the 418 
reflectivity of background for blood vessels, compromising oximetry measurements. For this reason, 419 
Hammer et al., (2008) introduced an empirically derived calibration factor to account for the effect of 420 
retinal melanin pigmentation in two-wavelength oximetry.[29] In subjects with minimal retinal melanin 421 
pigmentation, the retinal tissue is so transparent that the blood vessels of the choroid – at the back of the 422 
retina - can be directly studied by MSI oximetry.[14]  423 
Other chromophores such as adipose fat and yellow pigment could affect the spectra of tissue at visible 424 
wavebands, but the influence of such pigments is not normally accounted for in oximetry. Absorption 425 
by water is not typically a concern for oximetry, because water only strongly absorbs light at >1000 nm, 426 
which is beyond the waverange of 400 – 800 nm typically used for oximetry.  A thorough review on 427 
absorption and scattering properties of these miscellaneous tissue chromophores is provided by Jacques 428 
et al., (2013).[79] 429 
 430 
3.3. Optical scattering by tissue   431 
Optical scattering by tissue is due to inhomogeneities in the refractive index of the tissue, e.g. cells or 432 
blood vessel walls. Consequently, such scattering is well-described by Mie scattering theory, where the 433 
scattering structures are similar dimension to the wavelength of light being scattered. Unlike Rayleigh 434 
                                                     
** A chromophore is a molecule that absorbs visible light, responsible for the characteristic colour of a substance 
when viewed with the eye. 
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scattering, Mie scattering does not strongly vary with wavelength, but becomes more important when 435 
absorption is reduced, e.g. at red and near-infra red wavelengths. The scattering properties of the 436 
skin,[81–83] the retina,[84,85] the sclera,[86] and blood[87] are well characterised.  437 
 438 
Optical scattering by overlying tissue can alter the transmission of blood vessels.[7] For example, in the 439 
highly scattering tissue of the choroid scattering results in blood vessel appearing to be brighter than the 440 
surrounding tissue, producing a negative OD. This is particularly apparent when the reflectivity of 441 
surrounding tissue is low. In such situations, two-wavelength oximetry calibration is not applicable, but 442 
nevertheless indications of relative OS may instead be reported in terms of ODR.[14] The best example 443 
of this phenomenon has been reported by Kristjansdottir et al., (2013).[14] 444 
Although generally unavoidable, scattering by skin tissue can be reduced by the application of optical 445 
clearing substances, which match the refractive index of inhomogeneities within tissue, thus reducing 446 
scattering. Optical clearing agents are typically used to reduce scattering in skin to provide deeper and 447 
clearer optical imaging, however, they may alter various tissue properties may require invasive 448 
injections for maximum effectiveness.[88,89] Hence, optical clearing agents are not commonly used in 449 
oximetry experiments. 450 
 451 
3.4. Other challenges of imaging through tissue  452 
Aside from absorption by chromophores and optical scattering, there are other challenges associated 453 
with imaging blood vessels through tissue, including limited depth penetration of light, tissue-specific 454 
wavelength filtering effects, polarization dependent effects, tissue geometry, and tissue auto-455 
fluorescence.  456 
 457 
The penetration depth of light in tissue is highly variable, with blue and green wavelengths generally 458 
limited to a penetration depth of < 2 mm due to strong absorption and scattering.[90,91] However, 459 
wavelengths between 600-1000 nm can pass further through tissue due to reduced absorption at these 460 
wavelengths, enabling applications such as pulse oximetry. This waveband is sometimes referred to as 461 
“the biological window”. Photoacoustic imaging techniques get around this limit by combining optical 462 
excitation with ultrasonic detection (see Section 6.4). 463 
 464 
Specific tissue may also have associated wavelength-filtering effects: for example, the lens within the 465 
human eye acts an ultraviolet filter, with the  transparency of the lens decreasing across all wavelengths 466 
with age.[92] Cataracts can also influence oximetry measurement by effectively applying a spectral-467 
filter function over images, consequently altering ODR of blood vessels imaged within the eye.[93,94]  468 
 469 
Tissues may also exhibit birefringence, caused by parallel strands of fibrous tissue. In the eye, the  sclera, 470 
the cornea, and the retinal nerve fibre layer are generally birefringent.[95–98] Birefringence is 471 
particularly important for studies utilising orthogonally polarised illumination to mitigate reflections 472 
(see Section 3.7) because birefringence can result in uneven tissue reflectivity that can cause challenges 473 
for oximetry. 474 
 475 
Defocus due to tissue curvature or bulk motion can significantly reduce the apparent contrast of blood 476 
vessels with respect to other features. Defocus due to tissue curvature is a particular challenge for both 477 
endoscopic and ocular imaging. To minimise defocus, retinal oximetry studies typically limit 478 
measurements to a well-defined, well-constrained region near the optic disc[99]; when imaging the 479 
surface of the eye, (the sclera), maximising the depth of field is a good strategy for minimising any 480 
potential defocus.[100] 481 
 482 
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Some tissues may exhibit auto-fluorescence when illuminated with the appropriately exciting 483 
wavelengths (typically ultraviolet or blue light). For example, proteins within blood plasma will strongly 484 
auto-fluoresce under blue illumination (e.g. ~400 nm), and emit at longer wavelengths (e.g. ~500 485 
nm),[78] and auto-fluorescence of retinal tissue (excitation ~ 470 nm, emission at ~600 nm) is strong 486 
enough to be utilized as a retinal imaging modality in its own right.[101] To date, auto-fluorescence has 487 
not yet been considered as a source of potential errors in oximetry, but nevertheless it is prudent to be 488 
wary of, and minimise, any tissue auto-fluorescence in oximetry experiments. 489 
3.5. Scattering by blood   490 
3.5.1. General considerations 491 
Optical scattering by blood should be considered when interpreting transmission of blood vessels for 492 
oximetry. In blood, light is predominately Mie scattered by individual red blood cells (RBCs) which 493 
make up approximately 44% of blood volume, and which are each ~6 – 8 µm in diameter with a concave 494 
shape (see Figure 4).[77] Proteins in blood plasma also contribute Rayleigh scattering effects, but the 495 
magnitude of this scattering is 100-1000 times less than scattering from RBCs.[77] The scattering 496 
properties of blood can alter due to several factors, including: changes in OS,[102] change in % of RBCs 497 
by volume (the haematocrit),[103] changes in overall blood volume (e.g. due to water drinking),[104] 498 
and changes in blood flow rate.[64,105]  499 
 500 
The quantitative parameters that describe the scattering of light by blood are the absorption coefficient 501 
( 𝜇𝑎) [units: cm
-1M-1]; the scattering coefficient (𝜇𝑠) [units: cm
-1]; the anisotropy factor (𝑔) 502 
[dimensionless]; and the effective scattering coefficient: 𝜇′𝑠  =  𝜇𝑠(1–  𝑔) [units: cm
-1].[77] The 503 
anisotropy factor is defined as: 𝑔 = 𝑐𝑜𝑠(𝜃), where  𝜃 is the typical angle at which incident light is 504 
deflected by a scattering event. 𝑔 = 0 indicates no forward scattering, and 𝑔 = 1 indicates complete 505 
forward-scattering. For whole blood, 𝑔 has been estimated to be ~ 0.985 - 0.997, i.e. highly forward-506 
scattering.[57]  507 
 508 
 
Figure 4. Depiction of red 
blood cells showing their 
biconcave shape. Figure 
reproduced from the public 
domain.[106] 
3.5.2. The influence of oxygen saturation on optical scattering by blood  509 
OS plays a role in determining the optical scattering properties of blood by mediating the transmission 510 
of blood. Monte Carlo simulations by Friebel et al., (2009) demonstrated that an increase in 𝜀𝜆 will 511 
decrease 𝑔. Thus, if a change in OS results in a decreases in the optical transmission of blood, then the 512 
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degree of forward scattering through blood will also decrease, resulting in a further decrease in 513 
transmission, not described by the Beer-Lambert law.[102] 514 
3.5.3. The influence of blood flow speed on scattering and reflection by blood  515 
The orientation of RBCs within flowing blood is dependent on blood flow velocity: if blood is static or 516 
flowing very slowly, then RBCs will be randomly orientated, and biconcave in shape. However, if blood 517 
is flowing, then RBCs will preferentially align with the flow, and elongate in the direction of flow due 518 
to shear stress (see Figure 5).[107] This alignment consequently alters the optical properties of blood, 519 
particularly backscattering. Klose et al., (1972) demonstrated that preferential alignment of RBCs under 520 
flow results in an increase of backscattered light from blood vessels.[105] Schweitzer et al., (1999) 521 
demonstrated that once all RBCs are orientated in the same direction, then the back-scattered light would 522 
reach a maximum. For a 50 µM diameter blood vessel, this critical flow speed corresponding to complete 523 
preferential alignment was found, empirically, to be 6.4 mm/s.[64] Thus, it is important that blood flow 524 
speed is considered in oximetry experiments because blood at low, moderate, and critical flow rates will 525 
have different optical back-scattering properties. Back-scattering from blood can produce specular 526 
reflections, which can introduce errors into oximetry (see Section 3.6). 527 
 528 
 
Figure 5. Depiction of the preferential alignment of red blood cells under flow due to shear stress. 
Top: no flow. Bottom: under flow. A more detailed depictions of this phenomenon can be found in 
Cimalla et al., (2011).[107] Note, this depiction describes a relatively large blood vessel (e.g. 100- 
200 µm diameter), and is not valid in capillaries (<10 µm in diameter) were red blood cells 
elastically deform to flow through capillaries.[108] 
3.6. Mitigating specular reflections from blood vessels  529 
Illumination light can create a bright specular reflection from a blood vessel, typically manifesting in 530 
the centre of a vessel. Such specular reflections can introduce errors in the estimation of transmission of 531 
a blood vessel and thus induce errors in MSI oximetry (see Figure 6). There are several methods for 532 
mitigating specular reflections. One strategy is to use off-axis illumination of blood vessels, thus moving 533 
the position of specular reflections to a less intrusive angle. However, off-axis illumination creates 534 
shadowing effects and is impractical for many in vivo applications, such as retinal imaging, where off-535 
axis imaging requires invasive procedures.[109] Another, simpler, approach is to modify blood vessel 536 
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transmission-measurement algorithms to compensate for reflections. With this approach, the potential 537 
for systematic errors should be carefully considered. Alternatively, annular illumination can be 538 
employed to back-illuminate blood vessels via diffuse scattering via surrounding tissue; totally 539 
eliminating specular reflection from the blood vessel.[110] 540 
Perhaps the most elegant approach to mitigate specular reflections is to use orthogonal polarisation 541 
imaging (OPI). In OPI the illumination light is linearly polarised, but becomes depolarized when it 542 
undergoes multiple scattering by tissue. In contrast, specularly reflected light, does not lose its 543 
polarisation because it does not undergo multiple scattering. Thus, by placing a linear polariser in the 544 
imaging path, with polarisation axis orientated orthogonally to the polarisation axis of the illumination 545 
light, specular reflections can be completely mitigated, whilst light that has undergone multiple 546 
scattering by tissue is imaged.[111]  547 
 548 
 549 
 550 
 
Figure 6. An ideal blood vessel intensity-profile cross section, 
with and without specular reflection. Specular reflections 
increase the apparent intensity (Iv) in the centre of a blood 
vessel. 
3.7. Optical paths through blood vessels  551 
Light does not simply follow a single path through blood vessels; scattering, reflection, absorption all 552 
play a role in determining the path of individual photons through blood. Scattering is described in terms 553 
of scattering probabilities, with the outcome of each event determined in a pseudo-random manner. 554 
Hence, Monte Carlo simulations are a useful method for investigating light paths through blood vessels 555 
because they simulate many individual photons propagating through blood. Predictions by Monte Carlo 556 
models can be compared to experimental data to assess optical models or to test predictions of 557 
parameters, e.g. the scattering anisotropy factor of blood, g (see Section 3.5.1). 558 
Hammer et al., (2001) [112] used Monte Carlo simulations to investigate different light paths through 559 
blood vessels when the blood vessels were illuminated by retinal fundus cameras and scanning laser 560 
opthalmoscopes (SLOs). Simulations were conducted for light in the waveband 520 -586 nm and 561 
investigated model blood vessels 25 – 200 µm in diameter. Examples of the light paths through blood 562 
vessels simulated in this study are shown in Figure 7. They found that back-scattered and single-pass 563 
transmitted light dominates for both fundus cameras and SLOs. However, compared to fundus cameras, 564 
SLOs have a higher degree of backscattered light, with relatively larger double pass transmission 565 
contribution.[112] 566 
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Rodmell et al., (2014)[110] conducted Monte Carlo simulations to investigate if vessels can be diffusely 567 
illuminated by illuminating nearby tissue, instead of directly illuminating blood vessels, e.g. by using a 568 
confocal SLO illumination scheme. Their study concluded that if the tissue surrounding a vessel is 569 
illuminated, then the vessel will be effectively back-illuminated.[110] This finding has subsequently 570 
been used to simplify multispectral oximetry models by enabling the use of annular illumination to 571 
eliminate double-pass contributions in MSI oximetry models.[9,70] 572 
 573 
 574 
Figure 7. Potential light paths through a blood vessel. (A) specular reflection. (B) backscattered. (C) 575 
double pass. (D) Single-pass (back illuminated).[112] 576 
3.8. Rattlesnake artefacts  577 
A common artefact in oximetry is “rattlesnaking”, where estimated OS spuriously varies along the 578 
length of a blood vessel, causing a stripey, “rattlesnake” pattern to appear when OS is visualized as a 579 
colour-coded map (see Figure 8). Spurious variations in estimated blood vessel transmission can arise 580 
due to a number of reasons, including variations in red blood cell concentration, optical scattering, 581 
background pigmentation, and vessel-fitting errors. To minimize the adverse effects of rattlesnaking, 582 
OS is often averaged along the length of a blood vessel or vessel segment to reduce random variations 583 
in OS prior to further analysis. 584 
 585 
Figure 8. Two-wavelength retinal oximetry images of a healthy subject (left) and a subject with chronic 586 
obstructive pulmonary disorder (right). Rattlesnaking artefacts are apparent in both subjects. Figure 587 
reproduced from Eliasdottir et al., (2017) under a Creative Commons BY 4.0 licence.[113] 588 
3.9. Oxygen diffusion  589 
 590 
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Oxygen diffusion has recently emerged as both a challenge and a tool for oximetry of blood vessels 591 
exposed to ambient air, e.g. in bulbar conjunctival and tendon oximetry.[10,15] Oxygen will naturally 592 
move from regions of high partial pressure of oxygen (pO2) (e.g. the air) to areas of lower pO2 (e.g. 593 
exposed blood vessels), until a pO2 equilibrium is reached. This will raise the OS of blood. Nominal pO2 594 
of blood is ~ 100 mmHg and ~ 40 mmHg for arteries and veins respectively, whereas nominal pO2 of 595 
air at sea level is much higher, at ~160 mmHg.[27] Therefore, if blood reaches equilibrium with ambient 596 
air, then the OS of blood will be close to 100%. The rate of oxygen diffusion for air to blood is described 597 
by Fick’s law of diffusion, which incorporates two main factors: the pO2 gradient, and the oxygen 598 
diffusivity of any tissue between the air and the blood. The oxygen diffusivity of tissue depends on tissue 599 
thickness and composition.[114–117] 600 
Oxygen diffusion will occur when blood vessels are exposed to the ambient air. Foe example. in the first 601 
MSI oximetry study of the bulbar conjunctival microvasculature (located on the surface of the eye), 602 
MacKenzie et al., (2016)[15] observed rapid oxygen diffusion from ambient air into hypoxic bulbar 603 
conjunctival microvessels when the eyelid was open. This oxygen diffusion occurred in a timescale of 604 
just a few seconds, with 50% of the oxygen diffusion occurring on average in 3.4 ± 1.4 seconds (see 605 
Figure 10). Closure of the eyelid created a barrier to oxygen diffusion from ambient air. Due to this 606 
oxygen diffusion, it is thought that all bulbar conjunctival vessels will be highly oxygenated when 607 
exposed to air after a few seconds.[15]  608 
This diffusion oxygenation effect has been exploited by other studies. Sarkar et al., (2017) exploited 609 
oxygen diffusion to remove OS as a source of uncertainty in their experiments to non-invasively measure 610 
bulbar conjunctival haemoglobin concentration for anemia diagnosis.[118] van der Putten et al., 611 
(2017)[9] utilized reoxygenation by diffusion as an intervention to alter OS and confirm oximetry 612 
capability.[9] It has been suggested that oxygen diffusion rates could be investigated as a parameter for 613 
the measurement of microvascular function, e.g. to investigate vessel wall thickening due to diabetes, 614 
but further research on this matter is required.[15]  615 
Oxygen diffusion is a concern in studies where blood vessels are surgically exposed, because oxygen 616 
diffusion can spuriously increase blood OS. A test for ongoing oxygen diffusion into surgically exposed 617 
venules was reported by van der Putten et al., (2017)[7] They reasoned that if oxygen diffusion was 618 
occurring, then blood would become more oxygenated as it flowed down the length of a vein. In their 619 
particular case, van der Putten et al. did not observe an OS gradient along the length of veins examined. 620 
indicating no significant oxygen diffusion into these veins.[7] 621 
In the retina, oxygen diffusion is not a concern, because retinal blood vessels are shielded from air by 622 
the tissue of the eye. However, the potential effects of oxygen diffusion should be carefully considered 623 
in any oximetry application where blood vessels may be exposed to air. For example, if invasive 624 
intravitreal retinal illumination is used, then diffusion may cause spurious changes in OS.[109] 625 
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 626 
Figure 9. Oxygen diffusion from ambient air causes rapid reoxygenation of hypoxic 627 
bulbar conjunctival blood vessels (blue line). The ODR of episcleral vessels (red line) 628 
and fingertip pulse oximeter OS (green line) remain constant because these blood vessel 629 
beds are embedded within tissue and thus do not undergo diffusion. The x-axis is 630 
elapsed time after the subject opens their eyelid. Error bars represent the standard error 631 
of the mean. For clarity, pulse oximetry error bars of ± 2% OS are not shown. NB: in 632 
this diagram SO2 denotes OS. Figure reproduced from MacKenzie et al., 2016 with 633 
permission.[15] 634 
3.10. Multi-OS laminar flow in trunk veins 635 
 636 
It is common for multiple tributary venules to merge into a single larger, trunk vein. This results in 637 
multiple non-mixing, laminar, blood streams of varying OS flowing within trunk veins, producing a 638 
heterogeneous OS distribution. This will introduce errors into estimation of OS, because all oximetry 639 
algorithms to-date assume a single homogenous OS across the breadth of a vessel.  640 
 641 
This multi-OS laminar flow phenomenon is most readily observed during retinal fluorescein 642 
angiography, but can also be verified with flow-sensitive optical coherence tomography,[119] and 643 
multispectral imaging.[59] Hendargo et al., (2015) have provided the clearest demonstration of the 644 
multi-OS laminar flow problem.[59] However, at the time of writing, no method to estimate and/or 645 
compensate for the error this multi-OS laminar flow has been developed. 646 
 647 
4. Image processing for multispectral imaging oximetry   648 
4.1. Image acquisition 649 
Image acquisition for multispectral imaging generally follows best practice for general scientific 650 
imaging in that images should be well-exposed so as to have a good signal to noise ratio, dark current 651 
and random noise in the detector should be accounted for, and images should be acquired at the highest 652 
possible bit-depth to ensure maximum sensitivity to changes in intensity across the scene. Additionally, 653 
images should be saved in uncompressed format (e.g. .TIFF), because saving images in a compressed 654 
format (e.g. .jpg) can result in artefacts (see Figure 10).  655 
Sensitive monochromatic scientific detectors (e.g. CCDs and CMOS detectors) are best suited for MSI 656 
oximetry due to their low noise levels, high sensitivity, fast read out rates, and generally good hardware 657 
to control software connectivity. Some oximetry studies have utilized consumer single lens reflex (SLR) 658 
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cameras as detectors. Some oximetry studies have utilized consumer single lens reflex (SLR) cameras 659 
as detectors, although good software control and high data acquisition rates are typically harder to 660 
achieve compared to scientific detectors.[7] 661 
 662 
Figure 10. The scene in sub-figure A was acquired simultaneously in 663 
two image formats: RAW (uncompressed) and .jpg fine (compressed). 664 
The yellow line indicates the line-profile selected for analysis. (B) The 665 
corresponding intensity line-profile can be seen to differ between 666 
formats, with the .jpg image showing increased apparent intensity the 667 
centre of the line profile. If this line profile were of a blood vessel, these 668 
.jpg compression artefacts would result in a different estimation of 669 
blood vessel transmission, and thus introduce systemic errors in the 670 
estimation of OS. 671 
4.2. Co-registration of multispectral images 672 
Prior to MSI oximetry analysis, co-registration of multispectral images is essential to ensure that the 673 
same region of a blood vessel is analyzed in each image at a different waveband. Broadly speaking, 674 
there are two main classes of multispectral image co-registration algorithms: feature-matching co-675 
registration and cross-correlation co-registration. 676 
4.2.1. Feature-matching co-registration algorithms  677 
Feature-matching algorithms are best applied to co-registration of “feature rich” images: i.e. images 678 
with features that exhibit strong contrast and distinct boundaries. In brief, feature-matching algorithms 679 
detect distinct features in different images, determine which points corresponds with detected points in 680 
other images, estimate the relative displacement of these matching points, and then compute a 681 
corresponding affine transform to apply operations such as rotation, scaling, shear, and reflection; 682 
resulting in co-registration of the two images (see Figure 11). Affine transforms are defined as 683 
transforms that preserve linearity of features, along with the ratio of distances.[120] 684 
For feature-matching co-registration algorithms to perform well, a large number of potential registration 685 
points must be used, requiring numerous distinct features. However, automatically identifying enough 686 
unique distinct features can be highly challenging in biological imaging. For example, feature-matching 687 
algorithms can struggle to detect blood vessels across different wavebands, because the contrast of blood 688 
vessels compared to background tissue varies greatly between green and red wavebands (see Figure 12). 689 
 690 
 
 
24 
 
24 
 
 
Figure 11.  Principle of a feature-matching image co-registration 
algorithm. (A) Main image. (B) Arbitrarily displaced image. (C) Distinct 
unique features identified are identified in image A. (D) Matching 
distinct and unique features are identified in image B, and used to 
compute an image transform to co-register images A and B. 
 691 
 
Figure 12. Retinal images of two different subjects 
at 577 nm and 600 nm. Top: a subject with low 
degree of retinal pigmentation. Bottom: a subject 
with a high degree of retinal pigmentation. The 
bright white region is the optic disk. 
4.2.2. Cross-correlation co-registration algorithms  692 
Unlike feature-matching algorithms, cross-correlation image co-registration algorithms can be applied 693 
to images with poor feature contrast. However, this comes with the requirement of considerably more 694 
computational processing time than feature-matching algorithms. Cross-correlation-based registration 695 
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algorithms work by overlaying two images and calculating the cross-correlation function of the two 696 
images, which can be calculated rapidly by fast Fourier transform techniques. The algorithm will then 697 
iteratively apply incremental transforms in one of the images, checking the cross-correlation function 698 
after each iteration, until a global maximum is reached. However, reaching a global maximum can 699 
require many iterations of image transformation, and thus can be computationally time-intensive. A 700 
logic flow-chart for a cross-correlation algorithm is shown in Figure 13. 701 
 702 
 
Figure 13. An exemplar logic flow-chart for a cross-correlation image 
co-registration algorithm. Rectangular nodes represent operations. 
Diamond nodes represent decision points. 
 703 
4.2.3. Other challenges of in vivo image registration  704 
Automatic image registration algorithms rely on the assumption that features in the scene are 705 
unchanging. This assumption is not always true, especially when using time-sequential MSI in vivo. For 706 
example, subject motion can introduce motion blur or defocus,[121] and conjunctival blood vessels are 707 
semi-mobile relative to background tissue.[15] In such challenging circumstances, semi-automatic 708 
registration using human input may be required to successfully identify features for successful co-709 
registration.[122] 710 
4.3. Estimating the transmission of blood vessels  711 
Estimation of the transmission of a blood vessel requires the measurement of three parameters:  712 
1. The intensity of light at the centre of the blood vessel (Iv) 713 
2. The intensity of light in the position corresponding to the centre of the blood vessel, if the 714 
blood vessel were not present (Io). 715 
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3. The diameter of the blood vessel. 716 
The typical approach to estimate these parameters is to analyse an intensity line profile across the blood 717 
vessel and nearby tissue, orthogonal to the direction of blood flow. The length of the line profile is 718 
arbitrary, but as a rule of thumb, a line profile length equivalent to three times the blood vessel diameter 719 
should suffice. Fischer et al., (2010) [123] proposed an algorithm to estimate the blood vessel diameter 720 
by defining the blood vessel walls as being the points in a line profile corresponding to greatest rate of 721 
change of intensity.[123] . Iv is typically estimated by fitting a function such as a Gaussian or parabola 722 
to the inside of a blood vessel, and recovering the intensity at the centre of the vessel. Io is typically 723 
estimated by plotting a linear fit to the surrounding tissue and extrapolating this linear fit to find the 724 
intensity at the position corresponding to the centre of the vessel. Figure 15 shows an example of a line 725 
profile fitting scheme. Further examples of line profile fitting with real line profiles can be found in van 726 
der Putten et al (2017).[5] 727 
 728 
 
Figure 14. Depiction of a vessel profile fitting 
scheme to estimate vessel diameter, and intensity 
inside the vessel (Iv) and the background intensity if 
the vessel were not present (Io). Reproduced with 
permission from MacKenzie et al., (2016).[15] 
5. Strategies for validation of multispectral imaging oximetry  729 
For many applications, MSI oximetry is the only oximetry technique capable of measuring OS in the 730 
blood vessels under investigation; no “gold standard” reference technique is available. Instead, MSI 731 
oximetry has to rely on somewhat indirect methods of validation. This section describes the various 732 
techniques which have been employed to validate oximetry and related assumptions. 733 
  734 
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5.1. Testing fundamental optical assumptions: Monte Carlo Simulations 735 
MSI oximetry algorithms incorporate multiple optical parameters to estimate changes in blood vessel 736 
transmission due to OS (see Section 2.4). Some parameters, such as the extinction coefficient of 737 
chromophores can be “hard-coded” from empirically measured values. However, other parameters, such 738 
as the degree of single pass and double pass light path contributions are challenging to estimate from 739 
experiments. Computational Monte Carlo simulations have been utilized as a method for testing and 740 
validation of optical assumptions which would otherwise be highly challenging or not possible to 741 
experimentally verify. However, Monte Carlo simulations have some drawbacks, mainly the expertise 742 
and expense associated with using computational simulation software. Additionally, researchers must 743 
be sure that the simulation software incorporates all relevant biological and optical parameters (e.g. 744 
tissue scattering functions) that are required for comprehensive optical simulation. For examples of how 745 
Monte Carlo simulations have been used to test assumptions in oximetry, refer to Sections 3.5.2 and 3.7.  746 
5.2. Validation with artificial phantoms 747 
Phantoms are artificial constructs designed to mimic blood vessels and tissue, for the purpose of testing 748 
oximetry measurements in “well controlled”†† scenarios. Phantoms typically incorporate ex vivo blood, 749 
with OS of that blood controlled by one of three methods: (1) bubbling oxygen-free gas through blood 750 
(e.g. Nitrogen or Argon) [124,125]; (2) by addition of a chemical such as sodium dithionite [46] or 751 
sodium bicarbonate [126]; or (3) by introducing an oxygen consuming micro-organism, such as yeast, 752 
to the blood.[127] OS of ex vivo blood can be verified by an ex vivo blood gas analyzer or partial pressure 753 
of oxygen probe, giving a useful comparison point for MSI oximetry.  754 
The design and construction of phantoms for MSI oximetry varies considerably depending on the tissue 755 
being simulated and MSI modality. For example, a retinal oximetry phantom may consist of blood filled 756 
capillaries within a water-filled model eye,[128] whereas a photoacoustic imaging phantom may consist 757 
of thick gelatinous agar slab embedded with blood-filled capillaries. Phantoms can also contain 758 
embedded test-targets to verify imaging performance.[129] Complex flow-cells designed to mimic the 759 
microcirculation in both flow speed and oxygen extraction have also been fabricated.[125] A full review 760 
of MSI phantoms across all modalities is beyond the scope of this tutorial, but a summary of phantoms 761 
for MSI oximetry in the eye can be found in Mackenzie et al., (2017).[6] 762 
5.3. In vivo validation strategies  763 
5.3.1. Blood gas measurement and pulse oximetry 764 
Blood gas analysis of ex vivo blood samples from large blood vessels (e.g. the antecubital vein) was the 765 
first technique used to validate in vivo retinal oximetry.[32] However, direct blood sampling is now 766 
rarely done due for several reasons: 1. Invasive procedures that cause a risk of harm to a subject should 767 
be avoided wherever possible [130];‡‡ 2. Suitably qualified staff are required to draw blood from a 768 
human subject; 3. Pulse oximetry has provided a quick, convenient, and non-invasive alternative in 769 
humans (as well as other animals); and 4. a standardized set of reference OS values has been adopted 770 
for two-wavelength retinal oximetry.[40] Ex vivo blood gas measurement, may however, be used in 771 
                                                     
†† Blood behaves quite differently in vivo and ex vivo; effects such as RBC aggregation are apparent in ex vivo 
blood but not in vivo blood. As such, phantoms utilising ex vivo blood are not necessarily “well controlled” in the 
traditional sense, but such phantoms do offer researchers control over key variables, e.g. OS, to a degree not 
possible in in vivo experiments. 
‡‡ Medical research involving human subjects must be carried out in accordance with the tenants of The 
Declaration of Helsinki, as set out by the World Medical Association.[130] 
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animal studies, where animal handling is done exclusively by suitably-trained and suitably-licensed 772 
individuals.[131] 773 
In humans, pulse oximetry can be applied to the fingertip and earlobe, whereas paw and carotid artery 774 
pulse oximeters are available for small animals. However, calibrating two-wavelength oximetry to 775 
arterial OS alone, leads to systematic errors in estimating venous OS (see Section 2.1.3 for more details). 776 
5.3.2. Oxygen sensitive nanophosphors and dyes 777 
The pO2 within blood can be non-invasively verified by imaging of nanophosphor probes with pO2-778 
dependent optical emission properties. In brief, nanophosphors refer to a class  of nanoscale 779 
phosphorescent biochemical probes that emit light and which are bound to a carrier protein, e.g. serum 780 
albumin. These nanophosphors typically require ultraviolet or blue excitation, which severely limits the 781 
depth to which they can be imaged within tissue, and which can induce photo-toxicity and tissue auto-782 
fluorescence.[132] Additionally, for robust measurement, these nanophosphors require complex 783 
phosphorescence lifetime imaging equipment. The combination of these factors mean that 784 
nanophosphor oxygen probes are not widely used for oximetry verification. Dmitriev et al., (2012) 785 
provide a review of the oxygen-sensitive nanophosphors available, along with associated 786 
challenges.[132] Shonat et al., (1997) is a good example of verifying MSI oximetry with 787 
nanophosphors.[65] 788 
5.3.3. Physiological interventions that alter oxygen saturation  789 
Physiological interventions such as systemic hyperoxia, systemic hypoxia, oxygen diffusion, and retinal 790 
flicker light stimulation enable researches to induce artificial changes in OS, distinct from physiological 791 
norms. This enables researchers to verify oximetry capability and test physiological response to 792 
stimuli.[6,7,133]  793 
In hyperoxia interventions, excess oxygen is administered to a subject, increasing systemic OS. Arterial 794 
OS is increased from ~95-97% to 100%, and venous OS increases by a larger margin. Temporary 795 
hyperoxia is thought to be a safer intervention than temporary hypoxia for subjects with cardiovascular 796 
impairment, although long-term hyperoxia itself can be damaging.[1] A particularly effective use of a 797 
temporary hyperoxia intervention was by Kristjansdottir et al., (2013). Their study used hyperoxia to 798 
demonstrate that choroidal vessels, even veins, are normally highly oxygenated.[14] Without a 799 
hyperoxia intervention, this insight would not have been possible.[6] 800 
In hypoxia interventions, air with reduced oxygen content is administered to a subject, decreasing both 801 
arterial and venous OS. Hypoxia is often associated with autoregulation vessel dilation that increases 802 
flow rate to maintain oxygen consumption.[28] Hypoxia interventions have led to insights that would 803 
otherwise not be possible, for example, MacKenzie et al., (2016)[15] utilised a hypoxia intervention to 804 
decrease OS and consequently observed rapid oxygen diffusion from air into bulbar conjunctival 805 
microvasculature.[15]  806 
Oxygen diffusion itself has recently emerged as a new intervention technique for oximetry. van der 807 
Putten et al., (2017) explosed blood vessels to air to alter OS via diffusion. This helped verify the 808 
oximetry measurement capability of their system, and confirmed low initial OS in the blood vessels 809 
studied.[10] 810 
In the retinal oximetry studies, flickering light illumination can be used to alter the metabolic demand 811 
of retinal tissue, and thus change uptake of oxygen by blood, altering OS. Unlike hyperoxia and hypoxia, 812 
flicker light stimulation does not change systemic OS.[6] 813 
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6. Multispectral oximetry imaging modalities  814 
6.1. Time-sequential multispectral imaging 815 
Conventional broadband imaging systems (e.g. retinal fundus cameras, microscopes, and endoscopes) 816 
can be adapted for MSI by spectrally filtering light prior to detection. There are two basic approaches 817 
to MSI oximetry: time-sequential MSI and snapshot MSI.  818 
In time-sequential imaging, images at various wavebands are acquired sequentially by switching spectral 819 
filters in either the illumination or detection path. Time-sequential filtering technologies include 820 
mechanically switched bandpass interference filters, liquid crystal tunable filters (LCTFs), and acousto-821 
optical tunable filters (AOTFs) (see Table 2 for a comparison of these technologies).[134] In addition, 822 
laser-based imaging techniques such as scanning laser ophthalmoscopes and photoacoustic techniques 823 
rely on time-sequential switching of laser illumination for spectral discrimination. 824 
Time-sequential MSI are poorly suited for observation of rapid biological processes which occur in the 825 
timescale of milliseconds (e.g. oxygen diffusion). For observing such rapid events, snapshot MSI is 826 
preferable.[59] 827 
 828 
Table 2. Comparison of electronically switchable optical filter technologies. 829 
Filter type Technology type 
Switching 
time 
Spectral 
Bandwidth 
Filter operation area and 
limitations 
LCTFs 
Layered liquid crystal 
filters. 
~50 ms ~ 10 nm. 
 
Large beam area (e.g. a 25 mm 
diameter aperture); polarization 
dependent filtering.[134] 
AOTFs 
Radio-frequency 
acoustic pressure wave 
modulated crystal 
transmission filter. 
~ 25 µs ~ 2 nm. 
Small beam area (e.g. a 
diameter of a few mm); requires 
well collimated light.[134]  
Bandpass 
filters 
Filters on a motor-
controlled switching 
mount. 
~1 s 
Typically ~ 10 
nm, but highly 
variable. 
Large beam area 
(e.g. 25 mm diameter aperture). 
6.2. Snapshot multispectral imaging 830 
Snapshot MSI technologies enable simultaneous acquisition of images at multiple spectral wavebands 831 
reducing oximetry artefacts,[59] and providing sub-second temporal resolution.[5]§§ A variety of 832 
snapshot MSI imaging systems have been produced,[135–139] but only two approaches have found 833 
substantial usage in oximetry: beam-splitter multiplexing and the  Image Replicating Imaging 834 
Spectrometer (IRIS). 835 
Beam splitter multiplexing is the simplest form of MSI and has been incorporated into several retinal 836 
oximetry systems.[16,39,40] In such systems, a broadband image is split into two or more paths by one 837 
                                                     
§§NB: an alternative MSI approach is to scan a point or line across a field of view, acquiring a spectral dataset 
via a spectrometer of the point “in a hyperspectral snapshot”.[38,158] However, this approach doesn’t enable 
image co-registration to account to subject motion, and hasn’t been widely applied for MSI oximetry. 
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or more beam splitters, producing a cascade of images which can be individually spectrally filtered. 838 
However, this approach becomes increasingly optically inefficient with the addition of more beam 839 
splitters.[59]  840 
The IRIS operates by employing a combination of wave plates and Wollaston prisms to spectrally de-841 
multiplex a broadband image in multiple images of distinct wavebands. IRIS systems can be tailored for 842 
specific applications, including oximetry.[140–142] IRIS has been utilized for measuring rapid oxygen 843 
release from red blood cells as well as observing fast oxygen diffusion into blood vessels.[5,15,28]  844 
6.3. Scanning laser ophthalmoscopes 845 
Scanning laser ophthalmoscopes (SLOs) utilize laser raster scanning to image the retinal reflectance for 846 
MSI oximetry. Compared to conventional retinal fundus cameras, SLOs can provide advantages in 847 
spatial resolution, contrast, and imaging field-of-view on the retina. Adaptive optics MSI SLOs have 848 
been developed to compensate for involuntary eye movement and thus enable imaging of the small 849 
retinal vessels.[143] Additionally, SLOs can be used in situations where retinal oximetry with a 850 
multispectral fundus camera would be challenging, such as imaging the retina of infants.[144] However, 851 
oximetry with MSI SLOs is fundamentally limited by the laser wavelengths available, resulting in sub-852 
optimal wavelength combinations for oximetry.[145]  853 
6.4. Photoacoustic imaging 854 
 855 
Since the mid-2000s, photoacoustic imaging techniques*** have emerged as powerful family of MSI 856 
imaging technologies that combine the advantages of optical absorbance contrast with the advantages 857 
of ultrasonic detection. Due to this unique combination of properties, photoacoustic techniques can 858 
provide deep-tissue maps of blood OS without the surrounding tissue.  In photoacoustic techniques, a 859 
high intensity laser pulse (< 10 ns duration) is incident upon blood. This pulse is absorbed, and the blood 860 
heats up, resulting in rapid expansion and contraction of the blood. This expansion and contraction 861 
generates ultrasonic pressure waves, which are detected by one or more ultrasound transceivers. The 862 
amplitude of ultrasound generated by the blood is directly proportional to how much light was absorbed 863 
by the blood at the illuminating wavelength. Thus, the ratio of ultrasound amplitude at two or more 864 
wavelengths can then be related to OS.  865 
Broadly speaking, there are two variants of photoacoustic imaging:  Photoacoustic Tomography (PAT), 866 
and Photoacoustic Microscopy (PAM), which offer different capabilities in terms of tissue depth 867 
penetration and spatial resolution. 868 
In PAT, tissue is diffusely illuminated with a laser pulse, and the resulting ultrasound signal is detected 869 
and reconstructed by computational back-projection algorithms means to form a 3D optical absorption 870 
distribution. When imaged at multiple wavelengths, this absorption can then be related to OS in a similar 871 
manner conventional oximetry theory (e.g. two-wavelength oximetry). PAT can image blood vessels 872 
embedded in up to several centimeters in tissue with a spatial resolution of ~ 10 – 100 µm.[146] Due to 873 
this capability, PAT is particularly advantageous for deep tissue applications such as whole body small 874 
animal imaging, brain imaging, and tumor imaging.  875 
PAM provides higher spatial resolution, but at the expense of imaging depth. In PAM, an image is built 876 
up by raster scanning a dual-focused optical beam and ultrasound detector across a target. The spatial 877 
resolution of PAM is determined by the convolution of the PSF of optical spot and ultrasound detector; 878 
therefore, higher resolution images require higher frequency ultrasound detectors, which greatly reduces 879 
                                                     
*** also known as optoacoustic imaging. 
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depth penetration through tissue.  Lateral spatial resolution of ~1 µm has been achieved with PAM, 880 
limited to a depth of ~ 100 µm in tissue.[147,148]  881 
Despite the impressive capabilities of PAT and PAM, these techniques require complex and expensive 882 
equipment, acoustically-coupled detection, and intense laser illumination. This makes photoacoustic 883 
techniques unsuitable for retinal imaging in humans. Further, increasing the temporal resolution of 884 
photoacoustic techniques is highly challenging.[149] These drawbacks present a considerable barrier of 885 
entry for new researchers to the field. Consequently, photoacoustic techniques are very powerful, but 886 
are not yet as widely applied to oximetry as time-sequential or snapshot MSI techniques. 887 
6.5. Spectroscopic Optical Coherence Tomography  888 
 889 
Spectroscopic Optical Coherence Tomography (S-OCT) is a variant of Optical Coherence Tomography 890 
(OCT) where the spectral absorbance of blood is inferred from the light back-scattered from blood 891 
vessels. S-OCT enables 3D maps of OS combined with 3D mapping of tissue structure. This capability 892 
can be used to create 3D maps tissue features such as blood vessel wall thickness,[150] however all 893 
OCT techniques suffer from shadowing from overlying tissue and blood vessels. S-OCT has been in 894 
development since the mid-2000s and has mainly been applied to retinal and brain imaging in animals 895 
due to illumination intensity limitations.[151] However, S-OCT oximetry in humans was recently 896 
demonstrated for the first time: an important and highly promising.[42,152] 897 
6.6. Dual-wavelength photothermal optical coherence tomography  898 
Dual-Wavelength Photothermal Optical Coherence Tomography (DWPT-OCT), like photoacoustic 899 
techniques, is based upon heating of blood by light. In DWPT-OCT, light incident upon a blood vessel 900 
is absorbed by blood, and heats the blood, producing small thermal perturbations (in the order of 901 
nanometers) proportional to the absorption coefficient of blood, and thus proportional to OS. The very 902 
small thermal perturbations are then measured by phase-sensitive optical coherence tomography.[153] 903 
However, to-date DWPT-OCT has been only utilized for oximetry in phantoms and the brain of 904 
anesthetized mice.[154–156]  905 
7. Summary and Conclusions  906 
The tutorial article is designed to serve as a broad introduction to MSI oximetry, whilst still also 907 
providing detailed content for the more experienced researcher. This article covers the optical theory of 908 
MSI oximetry, discusses the various MSI oximetry imaging modalities, and describes the many 909 
challenges encountered when applying MSI oximetry to in vivo application. 910 
For decades, two-wavelength oximetry has been the most widely applied oximetry imaging technique. 911 
However, multispectral oximetry algorithms techniques have demonstrated considerable promise for the 912 
myriad and diverse applications where reliable reference OS values are not yet known, pushing the 913 
boundaries of the field of oximetry. Nevertheless, calibration and verification of all oximetry techniques 914 
remains a fundamental challenge.  915 
Imaging modalities for MSI oximetry are rapidly progressing, with several powerful new imaging 916 
modalities emerging and providing capabilities beyond standard imaging techniques. Snapshot MSI 917 
technology provides sub-second oximetry capability, providing the ability to observed rapid biological 918 
processes such as microvascular oxygen diffusion and oxygen release from RBCs. Photoacoustic and 919 
endoscopic techniques provide deep-tissue oximetry measurement capability, particularly useful in 920 
applications such as the study of tumour development and rheumatoid arthritis. S-OCT is maturing as a 921 
viable technique for combined retinal oximetry and retinal tissue structure mapping in the human eye. 922 
 
 
32 
 
32 
 
Further, access to powerful computational processing techniques has enabled automatic oximetry 923 
analysis in a clinical setting.  924 
In addition to developments of MSI oximetry techniques, new OS-altering physiological interventions, 925 
have emerged. These interventions, such as temporary hyperoxia, temporary hypoxia, controlled oxygen 926 
diffusion, and retinal flicker-light stimulation have proven to be a powerful tool for researchers to assess 927 
oximetry capability, and explore physiological norms and responses. 928 
Historically, advances in oximetry technology have led to new insights into physiological norms and 929 
disease development. Given the recent pace of developments in the field of MSI oximetry, it is not 930 
unreasonable to expect further developments in the understanding of physiology and disease in the 931 
future. 932 
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